These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8259153)

  • 1. Vesnarinone for heart failure.
    Schwartz A; Grupp I; Grupp G
    N Engl J Med; 1994 Jan; 330(1):65; author reply 66. PubMed ID: 8259153
    [No Abstract]   [Full Text] [Related]  

  • 2. Vesnarinone for heart failure.
    Neely D
    N Engl J Med; 1994 Jan; 330(1):65. PubMed ID: 8259152
    [No Abstract]   [Full Text] [Related]  

  • 3. Vesnarinone for heart failure.
    Swedberg K; Wedel H
    N Engl J Med; 1994 Jan; 330(1):64; author reply 65. PubMed ID: 8259151
    [No Abstract]   [Full Text] [Related]  

  • 4. The search for the ideal positive inotropic agent.
    Packer M
    N Engl J Med; 1993 Jul; 329(3):201-2. PubMed ID: 8515793
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of Chinese-made vesnarinone on experimental heart failure of dog].
    Du J; Yang Z
    Hua Xi Yi Ke Da Xue Xue Bao; 1992 Jun; 23(2):178-80. PubMed ID: 1452153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Principles of treatment of left ventricular failure.
    Taylor SH; Silke B; Nelson GI
    Eur Heart J; 1982 Dec; 3 Suppl D():19-43. PubMed ID: 6761126
    [No Abstract]   [Full Text] [Related]  

  • 7. [Heart insufficiency: current aspects of physiopathology and therapy].
    Bolte HD
    Med Klin; 1981 Nov; 76(24):664-71. PubMed ID: 7311926
    [No Abstract]   [Full Text] [Related]  

  • 8. Amrinone: a promising new cardiotonic agent in the treatment of chronic cardiac failure.
    Likoff MJ; Weber KT; Andrews V; Janicki JS
    Herz; 1983 Aug; 8(4):199-205. PubMed ID: 6413341
    [No Abstract]   [Full Text] [Related]  

  • 9. Review of a dose-dependent increase in mortality with vesnarinone among patients with severe heart failure.
    LeJemtel TH
    Curr Cardiol Rep; 1999 May; 1(1):31. PubMed ID: 10980817
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe heart failure: balancing length and quality of life.
    Harv Heart Lett; 1999 Jun; 9(10):1-2. PubMed ID: 10233785
    [No Abstract]   [Full Text] [Related]  

  • 11. Dose dependence of chronic positive inotropic effect of vesnarinone in patients with congestive heart failure due to idiopathic or ischemic cardiomyopathy.
    Kass DA; Van Anden E; Becker LC; Kasper EK; White WB; Feldman AM
    Am J Cardiol; 1996 Sep; 78(6):652-6. PubMed ID: 8831399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathomechanisms of heart failure].
    Urbaszek W
    Z Arztl Fortbild (Jena); 1993; 87(8 Suppl 4):1-4. PubMed ID: 8105608
    [No Abstract]   [Full Text] [Related]  

  • 13. [Digitalis: characteristics, mechanisms of action, pharmacokinetics, indication, contraindication, clinical data, and side effects].
    Ashizawa N; Yano K
    Nihon Rinsho; 2007 May; 65 Suppl 5():14-8. PubMed ID: 17569306
    [No Abstract]   [Full Text] [Related]  

  • 14. Reassessment of digoxin and other low-dose positive inotropes in the treatment of chronic heart failure.
    Tauke J; Han D; Gheorghiade M
    Cardiovasc Drugs Ther; 1994 Oct; 8(5):761-8. PubMed ID: 7873474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and circulatory aspects of digitalis in heart failure.
    Storstein L
    Eur Heart J; 1982 Dec; 3 Suppl D():59-64. PubMed ID: 6761128
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative evaluation of the effect of digoxin, strophanthin, isolanid and corglycon on the indices of central hemodynamics, vascular tonus, circulating blood volume and myocardial contractility in acute heart failure].
    Tsyganiĭ AA; Kovalev NL; Kozlovskiĭ VI; Malinovskiĭ OP; Pen'kov GI
    Anesteziol Reanimatol; 1981; (3):44-8. PubMed ID: 7294441
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experiences and value of the use of positive inotropically acting substances in the treatment of myocardial insufficiency].
    Schlepper M
    Verh Dtsch Ges Herz Kreislaufforsch; 1982; 48():115-23. PubMed ID: 7187156
    [No Abstract]   [Full Text] [Related]  

  • 18. AR-L115BS in the treatment of heart failure.
    Thormann J; Kramer W; Schlepper M; Gottwick M
    Eur Heart J; 1982 Dec; 3 Suppl D():87-95. PubMed ID: 7160400
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vesnarinone restores contractility and calcium handling in early endotoxemia.
    Takeuchi K; del Nido PJ; Poutias DN; Cowan DB; Munakata M; McGowan FX
    Circulation; 2000 Nov; 102(19 Suppl 3):III365-9. PubMed ID: 11082415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.